Aprea
Membership Organizations · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
18 Robinson Road #15-01, Singapore, Cent...Phone Number
+65 69557850Website
aprea.asiaRevenue
$21.7 MillionIndustry
About Aprea
Aprea Org Chart
Is Aprea your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Aprea has recently received funding, and reach out quickly before it becomes old news!
Aprea, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Aprea is spiking on competitors!
Earning: See what the market has to say on Aprea recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Aprea
Product Launch: Get notified when Aprea launches new products
Click to see if Aprea had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Aprea has new funding data
Recommended Actions
Reach out to Masked Content who joined Aprea as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Aprea is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Aprea is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Aprea.
Aprea Tech Stack
A closer look at the technologies used by Aprea
Aprea News & Media
Tricor and APREA have jointly released “New Economy Real Estate in China - Market Review & Operational Guide 2023”, which introduces new economy real estate in China
HONG KONG SAR--(BUSINESS WIRE)--Tricor & APREA's "New Economy Real Estate in China - Market Review & Operational Guide 2023" offers logistics insights & operational best practices.FDA Lifts Clinical Hold On Aprea's Relapsed/Refractory Blood Cancer Studies
Aprea Therapeutics Inc (NASDAQ: APRE) can resume testing its eprenetapopt after a string of clinical holds on the therapy in August 2021. The Company plans to study the drug in new trials across various myeloid and lymphoid malignancies. read moreAprea Therapeutics Closes Out 2020 with Phase III Flop
Shares of Aprea Therapeutics plunged more than 77% in morning trading after the company announced its late-stage cancer combination treatment failed to meet its primary endpoint of complete remission rate.
Top Membership Organizations Companies
Frequently Asked Questions Regarding Aprea
The Asia Pacific Real Assets Association (APREA) serves as a leading advocate for the real assets sector in the Asia Pacific region. It provides resources and intelligence on real assets, including research, publications, and events aimed at fostering professional advancement and investor outreach. APREA's intended clients include industry professi... Read More